Invention Application
- Patent Title: NASAL FORMULATIONS OF METOCLOPRAMIDE
- Patent Title (中): METOCOPOPRAMIDE的鼻用制剂
-
Application No.: PCT/US2009069298Application Date: 2009-12-22
-
Publication No.: WO2010075444A3Publication Date: 2010-11-04
- Inventor: D ONOFRIO MATTHEW J , GONYER DAVID A , SHAH SHIRISH A , MADDEN STUART J
- Applicant: EVOKE PHARMA INC , D ONOFRIO MATTHEW J , GONYER DAVID A , SHAH SHIRISH A , MADDEN STUART J
- Assignee: EVOKE PHARMA INC,D ONOFRIO MATTHEW J,GONYER DAVID A,SHAH SHIRISH A,MADDEN STUART J
- Current Assignee: EVOKE PHARMA INC,D ONOFRIO MATTHEW J,GONYER DAVID A,SHAH SHIRISH A,MADDEN STUART J
- Priority: US14003408 2008-12-22
- Main IPC: A61K31/165
- IPC: A61K31/165 ; A61K9/12 ; A61K9/20 ; A61K31/14
Abstract:
Nasal formulations of metoclopramide, which remain stable and/or colorless upon storage over a period of time, are provided. Also provided are methods of treating disorders treatable with metoclopramide, comprising administering the nasal solutions to patients in need thereof.
Information query
